Association between plaque characteristics and side-branch compromise in left main bifurcation lesions after a single-stent crossover technique: insights from an optical coherence tomography study
Frontiers in Cardiovascular Medicine · 06.03.2026 · 13
DOI: 10.3389/fcvm.2026.1760407 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 06.03.2026. Verfasst von Jincheng Han und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The primary mechanism underlying side branch (SB) ostial compromise following main vessel (MV) stenting is the MV carina shift. However, the association between plaque characteristics or distribution and SB compromise remains unclear in patients with left main (LM) bifurcation lesions.
Methods
A total of 123 patients with LM bifurcation lesions were included in the final analysis. Preprocedural optical coherence tomography (OCT) assessment of the LM-to-left anterior descending artery (LAD) segment was performed, and patients were treated with a single-stent crossover technique. Quantitative coronary angiography was performed to evaluate LM, LAD, and proximal left circumflex artery (LCX). Left circumflex artery ostium (LCX-OS) compromise was defined as residual stenosis > 50% after MV stenting.
Results
LCX-OS compromise was observed in 33 patients in this study. Compared to the no compromise LCX-OS group, the compromise group had a higher frequency of plaque distribution in the LAD (90.9% vs. 65.6%, p < 0.001), more prominent calcified plaque characteristics (60.6% vs. 24.4%, p < 0.001), and a smaller LAD-LCX angle (81.2 ± 20.1 vs. 98.0 ± 25.7, p = 0.001). Adjusted multivariate logistic regression analysis revealed that plaques distributed in the proximal LAD (OR, 6.119; p = 0.011), calcified plaque (OR, 6.511; p = 0.001), and the LAD-LCX angle (OR, 0.966; p = 0.003) were independent predictors of LCX-OS compromise.
Conclusions
Plaque in the proximal LAD, presence of calcified plaque, and a smaller LAD-LCX angle may contribute to LCX-OS compromise following MV stenting in patients with LM bifurcation lesions. OCT has emerged as a promising tool for preprocedural risk stratification in LM bifurcation percutaneous coronary intervention, helping to mitigate the risk of LCX-OS compromise.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
- The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China.
Zitieren
APA
Han, J., Yu, H., Xu, M., Chen, T., Fang, C., Huang, X., Tan, J., Ma, L., Liu, H., Wang, Z., Wei, G., Liu, Y., Jia, H., & Yu, B. (2026). Association between plaque characteristics and side-branch compromise in left main bifurcation lesions after a single-stent crossover technique: insights from an optical coherence tomography study. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1760407
Vancouver
Han J, Yu H, Xu M, Chen T, Fang C, Huang X, et al. Association between plaque characteristics and side-branch compromise in left main bifurcation lesions after a single-stent crossover technique: insights from an optical coherence tomography study. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1760407
BibTeX
@article{Han2026,
author = {Han, Jincheng and Yu, Huai and Xu, Maoen and Chen, Tao and Fang, Chao and Huang, Xingtao and Tan, Jinfeng and Ma, Lijia and Liu, Huimin and Wang, Zhuozhong and Wei, Guo and Liu, Yanchao and Jia, Haibo and Yu, Bo},
title = {Association between plaque characteristics and side-branch compromise in left main bifurcation lesions after a single-stent crossover technique: insights from an optical coherence tomography study},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1760407}
}
EUVIMED